<- Go Home
Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Market Cap
$797.0M
Volume
3.0K
Cash and Equivalents
$3.0M
EBITDA
-$4.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$81.40
52 Week Low
$3.03
Dividend
N/A
Price / Book Value
96.98
Price / Earnings
-185.28
Price / Tangible Book Value
96.98
Enterprise Value
$789.2M
Enterprise Value / EBITDA
-197.73
Operating Income
-$4.7M
Return on Equity
43.18%
Return on Assets
-28.11
Cash and Short Term Investments
$8.0M
Debt
$85.7K
Equity
$8.2M
Revenue
N/A
Unlevered FCF
-$1.9M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium